In re HIV Antitrust Litigation
Case Number:
3:19-cv-02573
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Kessler Topaz
- Dillingham & Murphy
- Morrison & Foerster
- Kellogg Hansen
- Hilliard Shadowen
- Kirkland & Ellis
- Crowell & Moring
- Troutman
- Cahill Gordon
- Zelle LLP
- Wilson Sonsini
- Lockridge Grindal
- Pritzker Levine
- Boies Schiller
- Rivero Mestre
- White & Case
- Gibson Dunn
- Holland & Knight
- NastLaw
- Arnold & Porter
- Milberg Coleman
- Robins Kaplan
- Hausfeld LLP
- Duane Morris
- Kanner & Whiteley
- Spector Roseman
- Goodwin Procter
- Berry Silberberg
- Wiggin & Dana
- Roberts Law Firm US
- Faegre Drinker
- Hagens Berman
- Polsinelli PC
- Frederick M. Lehrer Attorney at Law
- Ballard Spahr
- Nussbaum Law Group
- Law Offices of Francis O. Scarpulla
- Hangley Aronchick
- Gibbons PC
- Radice Law Firm
- Whatley Kallas
- Proskauer Rose
- Sperling Kenny
- Miller Shah
- Glancy Prongay
- Baron & Budd
Companies
- Albertsons Cos. Inc.
- Fraternal Order of Police
- Humana Inc.
- Johnson & Johnson
- Gilead Sciences Inc.
- Blue Cross Blue Shield Association
- BlueCross BlueShield of South Carolina
- MSP Recovery
- Service Employees International Union
- CVS Health Corp.
- Amneal Pharmaceuticals Inc.
- Health Care Service Corp.
- Akros Pharma Inc.
- Florida Blue
- Viatris Inc.
- Aetna Inc.
- Johnson & Johnson Inc.
- Bristol-Myers Squibb Co.
- Zydus Pharmaceuticals Inc.
- Japan Tobacco
- Cipla Ltd.
- Centene Corp.
- The Kroger Co.
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
September 04, 2019
Gilead Says HIV 'No Generic' Suit Is Baseless
Gilead Sciences Inc. urged a California federal court on Wednesday to toss a suit alleging it created an HIV drug empire using shadowy deals to block generic competition, arguing that its dealings were entirely aboveboard.
-
July 26, 2019
Meet The Top Attys In Gilead's 'No Generics' Antitrust Rumble
Lead lawyers are locked and loaded in an explosive antitrust case accusing Gilead Sciences of pocketing billions of dollars by monopolizing life-saving HIV medicines via a dark conspiracy with fellow drugmakers. Here, Law360 unpacks the allegations and introduces the hot-shot attorneys on both sides of the case.
-
June 25, 2019
Big Pharma's Biggest New Cases Of 2019: Midyear Report
Multibillion-dollar lawsuits targeting major drugmakers emerged with astonishing frequency during the first half of 2019, threatening civil and criminal liability for all manner of alleged wheeling and dealing. Here, Law360 highlights the latest developments and upcoming action in the pharmaceutical world's hottest new cases.
-
May 14, 2019
Gilead Built HIV Drug Empire On 'No Generic' Deals, Suit Says
Despite abysmal scientific innovation, Gilead Sciences Inc. constructed an HIV drug empire worth tens of billions of dollars by devising shadowy deals to block the use of lower-cost generics in combo medicines, according to a proposed class action filed Tuesday.